Bio-ID Platform Commercialization

About Inanovate

Inanovate is a private, pre-revenue diagnostics company commercializing its proprietary Bio-ID platform, which integrates its foundational Longitudinal Assay Screening (LAS) technology. LAS is presented as a transformative method for protein analysis, analogous to real-time PCR for genomics, enabling highly multiplexed, quantitative serological testing without the need for serial dilutions. The company's mission is to enable access to the diagnostic power of the proteome for both clinical diagnostics and life sciences research, positioning its technology as a key enabler for next-generation diagnostics and therapeutics.